Welcome to the Starpharma Investor CentreStarpharma Holdings Limited is an Australian stock exchange listed biotechnology company with products based on its dendrimer technology platform. |
![]() |
Latest News & Announcements
Date of Starpharma’s Annual General Meeting 2023
Oct 2nd, 2023
Starpharma today announces, in accordance with ASX Listing Rule 3.13.1, that its 2023 Annual General Meeting (AGM) will be held at 2:00 p.m. (Melbourne time) on Wednesday, 29 November 2023.
Read MoreDEP® irinotecan combination data to be presented at international oncology conference (ASX Announcement)
Sep 27th, 2023
Starpharma today announces the presentation of data that demonstrate the benefits of combining DEP® irinotecan with other important classes of anti-cancer therapies, including immuno-oncology (IO) agents, in models of human colorectal cancer.
Read More
Reports & Presentations
Click here for financial reports archive
Date of Starpharma’s Annual General Meeting 2023
Oct 2nd, 2023
Starpharma today announces, in accordance with ASX Listing Rule 3.13.1, that its 2023 Annual General Meeting (AGM) will be held at 2:00 p.m. (Melbourne time) on Wednesday, 29 November 2023.
Read MoreDEP® irinotecan combination data to be presented at international oncology conference (ASX Announcement)
Sep 27th, 2023
Starpharma today announces the presentation of data that demonstrate the benefits of combining DEP® irinotecan with other important classes of anti-cancer therapies, including immuno-oncology (IO) agents, in models of human colorectal cancer.
Read More